Single Dose of Experimental Malaria Monoclonal Antibody Shows 77% Efficacy in Protecting Malian Children: Study
by The preliminary results of a mid-stage clinical trial conducted in Mali reveal that a single dose of an experimental malaria monoclonal antibody, developed by scientists …